Medicare Enrolled

Dr. Pragnesh Patel, MD

Allergy & Immunology · Altamonte Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
661 E ALTAMONTE DR, Altamonte Springs, FL 32701
4073393002
In practice since 2006 (20 years)
NPI: 1912973033 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Pragnesh Patel is an allergy & immunology in Altamonte Springs, FL, with 20 years in practice. Based on federal Medicare data, Dr. Patel performed 22,255 Medicare services across 1,001 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $98,239 from 44 pharmaceutical and/or device companies across 818 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 12% volume in FL$ $98,239 industry payments

Medicare Practice Summary

Medicare Utilization ↗
22,255
Medicare services
Top 12% in FL for allergy & immunology
1,001
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Omalizumab injection (Xolair) for asthma/allergy11,876$30$49
Allergy immunotherapy preparation4,208$11$20
Allergy skin test2,639$3$10
Allergy injection therapy, multiple injections1,434$8$40
Test for allergy using allergenic extract injected into skin532$6$12
Office visit, established patient (30-39 min)368$92$171
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle252$55$100
Professional service for single injection of allergen212$7$25
Office visit, established patient (20-29 min)193$63$117
Drug injection, under skin or into muscle190$11$40
Test to measure largest amount of air breathed in an out145$11$30
Test to measure expiratory airflow and volume131$19$65
New patient office visit (45-59 min)50$124$250
Test to measure expiratory airflow and volume changes before and after medication administration25$27$90
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$98,239
Total received (2018-2024)
Avg $14,034/year across 7 years
Top 10% in FL for allergy & immunology
44
Companies
818
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61,267 (62.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25,057 (25.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,914 (12.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17,725
2023
$9,708
2022
$11,525
2021
$8,631
2020
$11,149
2019
$18,132
2018
$21,370

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pharming Healthcare, Inc.
$59,757
Shire North American Group Inc
$12,365
CSL Behring
$4,869
Takeda Pharmaceuticals U.S.A., Inc.
$4,652
AstraZeneca Pharmaceuticals LP
$3,082
BioCryst US Sales Co., LLC
$2,907
Teva Pharmaceuticals USA, Inc.
$1,828
GENZYME CORPORATION
$1,133
GlaxoSmithKline, LLC.
$1,088
BioCryst Pharmaceuticals, Inc.
$875
PFIZER INC.
$839
Regeneron Healthcare Solutions, Inc.
$805
Genentech USA, Inc.
$609
Novartis Pharmaceuticals Corporation
$462
OptiNose US, Inc.
$445
ABBVIE INC.
$256
ALK-Abello, Inc
$240
Optinose US, Inc.
$229
Covis Pharma GmBH
$210
Kaleo, Inc.
$173
Octapharma USA, Inc.
$164
Grifols USA, LLC
$154
kaleo, Inc.
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$107
Covis Pharma B.V.
$88
Greer Laboratories, Inc.
$75
AIMMUNE THERAPEUTICS, INC.
$70
Aimmune Therapeutics, Inc.
$62
Covis Pharma GmbH
$62
SANOFI-AVENTIS U.S. LLC
$61
Amgen Inc.
$57
Ambu Inc.
$56
Blueprint Medicines Corporation
$44
Merck Sharp & Dohme Corporation
$44
Mylan Specialty L.P.
$39
Phadia US Inc.
$37
Galderma Laboratories, L.P.
$32
AbbVie Inc.
$25
Sunovion Pharmaceuticals Inc.
$22
Incyte Corporation
$19
Lundbeck LLC
$17
Hikma Pharmaceuticals USA
$16
Almatica Pharma LLC
$13
Bio Products Laboratory USA, Inc.
$8
Top 3 companies account for 78.4% of total payments
Associated products mentioned in payments ›
AIRSUPRA · ALVESCO · ANDEXXA · AREXVY · ASMANEX · AUVI-Q · AYVAKIT · AirDuo RespiClick · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREZTRI · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EOHILIA · EUCRISA · FARXIGA · FASENRA · GRALISE · Gammaplex · Gamunex-C · Grastek · Haegarda · Hizentra · ImmunoCAP · Kcentra · LONHALA MAGNAIR · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORALAIR · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PAZEO · PREVNAR - 13 · Palforzia · Prolastin-C Liquid · QVAR · REXULTI · RINVOQ · RUCONEST · Ryaltris · SPIRIVA RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · XOLAIR · Xembify · Xhance · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for allergy & immunology in FL.

Equivalent to $441 per 100 Medicare services performed
Looking for a allergy & immunology in Altamonte Springs?
Compare allergy & immunologys in the Altamonte Springs area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologys nearby

Geographic Context

Allergy & Immunologys within 10 mi
15
Per 100K population
3.2
County median income
$83,030
Nearest hospital
ASPIRE HEALTH PARTNERS
7.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), and high industry engagement (speaking/promotional, top 10%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Patel performed 11,876 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $98,239 from 44 companies across 818 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other allergy & immunologys in Altamonte Springs?
Dr. Patel's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →